2023 annual financial data
Boundless Bio, Inc. 2023 Operating margin
Boundless Bio, Inc. 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -54,796,000 USD and net income was -49,434,000 USD.
Operating cash flow was -46,855,000 USD.
Get free Boundless Bio, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -54,796,000 USD
- Net income
- -49,434,000 USD
- Operating cash flow
- -46,855,000 USD